Description
Relvar Ellipta 100/25mcg provides 30 daily doses of advanced respiratory relief for individuals managing asthma and Chronic Obstructive Pulmonary Disease (COPD). This innovative inhaler combines Fluticasone Furoate, an inhaled corticosteroid that reduces inflammation in the airways, with Vilanterol, a long-acting beta2-agonist that works to relax and widen the air passages. Used once daily, Relvar Ellipta helps to maintain clear airways, significantly reduce the frequency of breathing difficulties, and prevent exacerbations. It’s an essential part of a maintenance treatment plan, offering sustained control over symptoms and improving lung function for a better quality of life. (Note: Not for sudden breathlessness attacks.)
